SCHEMBL167253

SCHEMBL167253

BrCC1CCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27036740 1.00
SCHEMBL25541845 1.00
SCHEMBL28259630 0.97
SCHEMBL8280 0.85
SCHEMBL8544495 0.85
SCHEMBL11614918 0.85
SCHEMBL241360 0.83
SCHEMBL11565964 0.75
SCHEMBL10920802 0.75
SCHEMBL31550824 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115417835-A Itaconic acid oxetane derived free radical-cation hybrid monomer and preparation method and application thereof 同济大学 2022-12-02 CN claimed
CN-108947940-A A kind of synthetic method of 2- oxetane derivative 天津全和诚科技有限责任公司 2018-12-07 CN claimed
JP-52087497-A None JP disclosed
US-12630563-B2 Macrocyclic RIP2-kinase inhibitors ONCODESIGN S.A. (FR) 2026-05-19 US disclosed
US-20260125396-A1 MACROCYCLIC RIP2-KINASE INHIBITORS ONCODESIGN S.A. (FR) 2026-05-07 US disclosed
US-20260116881-A1 KIF MODULATOR COMPOUNDS AND METHODS OF USE IAMBIC THERAPEUTICS INC (US) 2026-04-30 US disclosed
US-12581252-B2 Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors RELAY THERAPEUTICS, INC. (US) 2026-03-17 US disclosed
US-12527763-B2 Pyrrole amide compound and use thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2026-01-20 US disclosed
EP-3941919-B1 PYRIDO-PYRIMIDINONE AND PTERIDINONE COMPOUNDS AS INHIBITORS OF ENDORIBONUCLEASE INOSITOL REQUIRING ENZYME I (IRE I ALPHA) FOR THE TREATMENT OF CANCER DISEASES. GENENTECH INC (US) 2025-12-24 EP disclosed
WO-2025228899-A1 FURTHER HETEROCYCLIC COMPOUNDS AS STING ANTAGONISTS AND THE USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-11-06 WO disclosed
US-20250270190-A1 KIT INHIBITORS BLUEPRINT MEDICINES CORPORATION 2025-08-28 US disclosed
EP-2320907-A1 THERAPEUTIC COMPOUNDS Merck & Co., Inc. (US) 2011-05-18 EP disclosed
WO-2010017047-A1 THERAPEUTIC COMPOUNDS MERCK & CO., INC. (US) 2010-02-11 WO disclosed
US-6465566-B2 REPEAT UNIT DERIVED FROM A HYDROXYL CONTAINING CARBOXYLIC ACID DISPERSANT OMNOVA SOLUTIONS INC. 2002-10-15 US disclosed
US-20020026006-A1 Anionic waterborne polyurethane dispersions containing polyfluorooxetanes DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT 2002-02-28 US disclosed
EP-0850258-A1 COMPOSITIONS OF POLYTETRAMETHYLENE ETHER GLYCOLS AND POLYOXY ALKYLENE POLYETHER POLYOLS HAVING A LOW DEGREE OF UNSATURATION BASF CORPORATION (US) 1998-07-01 EP disclosed
WO-1998001492-A1 COMPOSITIONS OF POLYTETRAMETHYLENE ETHER GLYCOLS AND POLYOXY ALKYLENE POLYETHER POLYOLS HAVING A LOW DEGREE OF UNSATURATION BASF CORPORATION (DE) 1998-01-15 WO disclosed
EP-0116658-B1 PROCESS FOR POLYMERIZATION OF VICINAL ALKYLENE OXIDE THE DOW CHEMICAL COMPANY (US) 1988-04-20 EP disclosed
EP-0126471-A2 Process for producing polyetherglycol Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1984-11-28 EP disclosed
JP-S5287497-A HIGH POLYMERIC PYROELECTRIC FILMS MATSUSHITA ELECTRIC IND CO LTD 1977-07-21 JP disclosed